Revealing metastatic castration‐resistant prostate cancer master regulator through lncRNAs‐centered regulatory network

BACKGROUND: Metastatic castration‐resistant prostate cancer (mCRPC) is an aggressive form of cancer unresponsive to androgen deprivation therapy (ADT) that spreads quickly to other organs. Despite reduced androgen levels after ADT, mCRPC development and lethality continues to be conducted by the and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraz, Rafaella Sousa, Cavalcante, João Vitor Ferreira, Magalhães, Leandro, Ribeiro‐dos‐Santos, Ândrea, Dalmolin, Rodrigo Juliani Siqueira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557827/
https://www.ncbi.nlm.nih.gov/pubmed/37644825
http://dx.doi.org/10.1002/cam4.6481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557827/
https://www.ncbi.nlm.nih.gov/pubmed/37644825
http://dx.doi.org/10.1002/cam4.6481

Ejemplares similares